These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 342669)

  • 1. The differential destructive and enhancing effects of anti-H-2K, H-2D, and anti-Ia antisera on murine skin allografts.
    McKenzie IF; Henning MM
    J Exp Med; 1978 Feb; 147(2):611-6. PubMed ID: 342669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
    Berden JH; Gerlag PG; Hagemann JF; Koene RA
    Transplantation; 1977 Sep; 24(3):175-82. PubMed ID: 339430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin graft enhancement studies with antigenic differences arising from the H-2K, H-2D, and H-2L loci.
    McKenzie IF; Henning MM; Morgan GM
    Transplantation; 1980 Jun; 29(6):439-43. PubMed ID: 6996234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
    McKenzie IF; Snell GD
    J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute destruction by humoral antibody of rat skin grafted to mice.
    Winn HJ; Baldamus CA; Jooste SV; Russell PS
    J Exp Med; 1973 Apr; 137(4):893-910. PubMed ID: 4120896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ia versus K/D antigens in immunological enhancement of tumor allografts.
    Duc HT; Kinsky RG; Voisin GA
    Transplantation; 1978 Apr; 25(4):182-7. PubMed ID: 635985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
    Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
    J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
    Rosenberg AS; Singer A
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera.
    Schwartz RH; David CS; Sachs DH; Paul WE
    J Immunol; 1976 Aug; 117(2):531-40. PubMed ID: 1084902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic bone transplantation in mice. II. Studies of the alloantibody response.
    Halloran PF; Lee EH; Ziv I; Langer F; Gross AE
    Transplantation; 1979 Jun; 27(6):420-6. PubMed ID: 380081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone grafting in inbred mice: evidence for H-2K, H-2D, and non-H-2 antigens in bone.
    Halloran PF; Lee E; Ziv I; Langer F
    Transplant Proc; 1979 Jun; 11(2):1507-9. PubMed ID: 382551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.